Reviva Pharmaceuticals Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -14.09 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
24.9 | 4.83 | 415.7% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-1.83 | -22.17 | -91.74% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-1.56 | 68.76 | -102.26% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 0 | 0% |
| ROE |
|
-686.53 | 9.61 | -7242.76% |
|
|
| ROA |
|
-165.65 | 0.3443 | -48219.18% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-188.66 | 15.45 | -1321.14% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.68 | -100% | -2.5 | -100% |
| Nеt Debt/Ebitda |
|
0.7676 | -3.44 | -122.33% |
|
|
| Debt/Ratio |
|
0 | 0.1986 | -100% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.32 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
10506286070.21 | -90.94 | -11552986761.77% | ||
| Growth impulse Net Income in 5 years |
|
4635281718.18 | -97.8 | -4739551959.08% | ||
| Growth impulse FCF in 5 years |
|
12892.82 | -108.72 | -11958.74% | ||
| Growth impulse EPS in 5 years |
|
539836144.2 | -142.05 | -380032584.48% |
IP Score
4.09/10
